Lexicon Pharmaceuticals, Inc.
LXRX· Nasdaq
LXRXLexicon Pharmaceuticals, Inc.
Filed May 10, 2013 · 10-Q · 40 days after period end · 0001062822-13-000023
| Metric | Q1 2012 | Q1 2011 | Q1 2010 |
|---|---|---|---|
| Revenue | $360.00K | $300.00K | $596.00K |
| Net Income | -$25.97M | -$29.87M | -$29.63M |
| EPS Diluted | -$0.05 | -$0.06 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lexicon Pharmaceuticals, Inc. · CIK 1062822 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 10, 2013 · 40 d after period end
